Clinical Trial Detail

NCT ID NCT04129515
Title NovoTTF-200A + Pembrolizumab In Melanoma Brain Metastasis
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Eric Wong, MD
Indications

melanoma

Therapies

Pembrolizumab

Age Groups: adult senior

Additional content available in CKB BOOST